Tag Archives: prescription drug

Latest Medicare Enroll News

Volunteers ready to assist with Medicare enrollment
During the month of October, we begin the annual enrollment process for the Medicare prescription drug plans, as well as Medicare Advantage plans. From Oct. 15 through Dec. 7, Medicare beneficiaries will have the chance to enroll, add or change plans …
Read more on Newport News Times

CVS/pharmacy to Help Patients Save Time and Money During Annual Medicare
WOONSOCKET, R.I., Oct. 14, 2014 /PRNewswire/ — CVS/pharmacy, the retail division of CVS Health , announced today that it will offer its senior patients an easy way to compare Medicare Part D prescription drug plans during the Annual Enrollment Period …
Read more on The Providence Journal

Hunterdon County reminds seniors about 2015 medicare open enrollment
Hunterdon County reminds seniors that the 2015 Medicare Open Enrollment period runs Oct. 15 to Dec. 7. Each year plans change, including what they cost and what they cover. Those who don't have prescription drug coverage can also enroll in a drug plan …
Read more on Hunterdon County Democrat

Consumers Direct Insurance Services of New Mexico Releases Dates and Times for its Medicare Seminar Series


Albuquerque, New Mexico (PRWEB) October 08, 2014

Late enrollment penalties, donut holes, calendar year maximums, catastrophic coverage – oh my. Medicare sure sounds frightening but don’t fret. With a little knowledge you’ll find it’s not nearly as scary as you may think.

Consumers Direct Insurance Services (CDIS), Inc., an Independent, Authorized Senior General Agent for Blue Cross and Blue Shield of New Mexico is gearing up for Medicare’s 2014 Annual Enrollment Period (AEP), which runs from October 15th through December 7th, with the release of its Medicare Seminar Series*.

CDIS’ Medicare Seminar Series, is a grassroots initiative that places experienced local insurance agents in a controlled learning environment for Medicare beneficiaries to gather essential plan benefit information while also providing a forum for answers to their questions.

“Consumers Direct Insurance Services of New Mexico is excited about its upcoming Medicare Seminar Series, because it gives us an opportunity to engage the local public and present all of the new plan options from Blue Cross and Blue Shield of New Mexico,” said Scott Loochtan, President of Consumers Direct Insurance Services, Inc. “Trying to decipher all of this material on your own can be daunting and that is why we offer this complimentary service to make the process much easier.”

The Medicare Annual Enrollment Period (AEP) is the one time of year that Medicare beneficiaries enrolled in either a standalone Medicare Part D prescription drug plan (PDP) or Medicare Advantage (MA) plan can make a change for the next year.

“The AEP is the insurance agent’s tax season,” noted Loochtan. “Medicare beneficiaries all over the country have been eagerly awaiting this time of year to review and analyze their plans so that they can secure the best options to meet their needs in the upcoming year.”

CDIS’ insurance agents go through a stringent Medicare Part D Prescription Drug Plan (PDP) and Medicare Part C, also known as Medicare Advantage (MA), continuing education and certification process each year in order to assist current and potential clients. This certification allows them to provide full service Medicare solutions while making themselves available in a variety of ways through technology, over the phone or in person appointments.

To register for one of CDIS of New Mexico’s Medicare Seminars please visit http://www.CDISofNM.com/seminars or call directly at 888.257.6640. There is limited seating for each seminar.

About Consumers Direct Insurance Services, Inc. (CDIS)

Consumers Direct Insurance Services, Inc., (CDIS), is an Independent, Authorized Senior General Agent for Blue Cross and Blue Shield of New Mexico, Oklahoma and Texas that were founded in an effort to bridge the gap between education and insurance. Headquartered in Riverwoods, IL, the company has an executive team with over 100 years’ experience that has been providing world-class healthcare guidance to over 20,000 active clients. For more information, please visit our state specific websites at http://www.CDISofNM.com, http://www.CDISofOK.com and http://www.CDISofTX.com.

*Not connected with or endorsed by the U.S. Government or the Federal Medicare program.







New Milliman Study: Hepatitis C Drugs Could Increase Medicare Part D Spending by $2.9 to $5.8 Billion in 2015

Washington D.C. (PRWEB) July 29, 2014

New high priced hepatitis C drugs will increase federal spending in Medicare Part D by a projected $ 2.9 to $ 5.8 billion next year, according to a new report by the actuarial firm Milliman released today by the Pharmaceutical Care Management Association (PCMA). Milliman projects that average Part D premiums could increase by as much as 8.6 percent in 2015 as a result of high-priced hepatitis C drugs, including Sovaldi and Olysio.

The study finds that the majority of new Federal spending will come from increased federal reinsurance subsidies. Medicare payments for Part D catastrophic coverage have grown considerably faster than other components of Part D spending. According to the Medicare Payment Advisory Commission, between 2007 and 2012, payments have increased at an average annual rate of 14 percent while nearly doubling from $ 8 billion to $ 15.6 billion.

Milliman bases its cost projections on the assumption that 15 percent to 30 percent of the Medicare Part D population estimated to be infected with hepatitis C will receive an $ 84,000 course of treatment in 2015.

“While most payers cover about 75 percent of an enrollee’s prescription drug costs, Medicare Part D covers 95 percent at high spending levels,” said PCMA President and CEO Mark Merritt. “The study shows taxpayers will bear the lion’s share of the increased drug costs for Medicare Part D beneficiaries taking hepatitis C drugs.”

Click here to read the new report.

Major findings from the report include:


    New hepatitis C drugs, including Sovaldi and Olysio, will increase 2015 federal spending on Medicare Part D by $ 2.9 to $ 5.8 billion for beneficiaries enrolled in Medicare Prescription Drug Plans (PDPs), an increase of $ 100 to $ 200 per beneficiary per year.

    Average monthly premiums for Medicare PDPs are projected to increase 4.3 percent to 8.6 percent next year as a result of new hepatitis C drugs, an increase of $ 17 to $ 33 per beneficiary per year.

Milliman’s analysis measured the impact of these new drugs on the Medicare Part D program; the study did not include the effect of the drug therapy on other medical costs.







Related Medicare Enroll Press Releases

How Do I Enroll in Medicare?

If you are new to Medicare, you can follow these easy steps to help to prepare for your Medicare enrollment.

Determine Your Eligibility The first step you need to take for Medicare enrollment is to find out if you are eligible. You should meet the eligibility requirements if you can answer yes to one of the following questions:
Are you age 65 or older?
Are you under 65 with certain disabilities?
Do you have End-Stage Renal Disease (kidney failure that requires transplant or dialysis)?

If you already receive Social Security Benefits, you will automatically be enrolled in Medicare Part A and B the month you turn 65. Three months prior to your birth date you should be

Americans Speak Out Against New FDA Regulations to Destroy Their Imported Medications


White Plains, NY (PRWEB) July 08, 2014

PharmacyChecker.com announced the publication on its website of almost 2000 comments by Americans who import medication for personal use that explain why they import medications and why they are concerned with new proposed FDA regulations for destroying prescription drug orders. The comments, such as the three examples below, are representative of the serious fears Americans have about the new regulations forcing them to go without needed medications (pharmacychecker.com/pdf/comments-by-americans-concerned-section-708-fdasia.pdf):

Morton Ross, Palm Harbor, FL 2014-04-03, “The Meds I take daily, are the difference between ‘Life and Death.’ I cannot afford the higher prices at local pharmacies.”

Darilyn Schlie, Fort Worth, TX 2014-04-03, “Without the ability to go outside the US, I will not be able to afford the medication I need.”

James Marshall, Nashville, TN 2014-04-03, “I have emphysema and could not afford my medications if not for being able to order some of them from outside the USA.”

Under Section 708 of the Food and Drug Administration Safety and Innovation Act (FDASIA), the FDA has new authority to destroy small packages of safe prescription drugs that are refused import. However, before implementing the new regulation the government must issue regulations – as a proposed rule – with a public comment period of 60 days. The regulations must allow consumers “appropriate due process” to “challenge the decision” of the FDA to destroy their imported prescription drugs. PharmacyChecker.com submitted public comments criticizing the proposed rule for not providing for appropriate due process and to offer recommendations for an improved final regulation. In the first paragraph of the public comments, Gabriel Levitt, vice president of PharmacyChecker.com, invoked the stories of real Americans who buy medication internationally:

“Prescription drug prices are often eight times more expensive in U.S. pharmacies than in foreign pharmacies [1]. About five million Americans import prescription drugs for personal use each year due to lower drug prices outside the U.S [2]. As part of a petition on Change.org launched in April of this year, almost 2000 self-identifying Americans left comments stating why they import prescription medication for their own use and their serious concerns about Section 708. The relevant FDA personnel should read them before drafting the final regulation to put Section 708 into effect.”

Mr. Levitt added: “The proposed rule neither provides appropriate due process as mandated by law, nor seeks to acknowledge the public health risks of seizing and destroying safe imported prescription drugs. Without proper and compassionate regulatory restraint, or even better, drug importation legal reform, Americans face serious potential adverse health effects if their medications are detained in the first place, not to mention refused import and destroyed because of Section 708.”

According to RxRights.org, a coalition of 80,000+ Americans, “Consumer and aging rights groups are expressing alarm that the rule will endanger the public health.” That group has launched a petition in the form of a letter to the new Secretary of Health and Human Services asking her to prevent regulations that could exacerbate obstacles to safe personal drug importation.

PharmacyChecker.com was founded by Tod Cooperman, M.D. in 2002 to help consumers safely save money on medication by identifying the lowest drug prices from reputable online pharmacies. PharmacyChecker.com independently checks the credentials of online pharmacies and pharmacy discount cards, and provides free and easy online comparisons of drug prices. It has no ownership in or from pharmacies or drug companies.

Contact: Gabriel Levitt, Vice President, PharmacyChecker.com: 718-387-4526 or gabriel.levitt(at)pharmacychecker(dot)com.

[1] See pharmacychecker. com/news/online_pharmacy_prescription_savings_obamacare_2013.asp [Last accessed 7/6/2014].

[2] Cohen RA, Kirzinger WK, Gindi RM, “Strategies used by adults to reduce their prescription drug costs,” NCHS data brief, no 119. April 2013. Hyattsville, MD: National Center for Health Statistics. 2013. NCHS data shows that approximately 2% of the adult U.S. population imports prescription medication for personal use on an annual basis.